Detalhe da pesquisa
1.
US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses.
JAMA;
2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771675
2.
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
J Infect Dis;
2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687898
3.
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
BMC Infect Dis;
24(1): 300, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454352
4.
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
J Infect Dis;
2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390968
5.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep;
73(8): 168-174, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421935
6.
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines.
Nat Commun;
15(1): 254, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177116
7.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Clin Infect Dis;
78(3): 746-755, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972288
8.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis;
2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041853
9.
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022.
medRxiv;
2023 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014151
10.
Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to Acceptance.
Ann Intern Med;
176(12): 1670-1671, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011706
11.
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022.
Emerg Infect Dis;
29(12): 2442-2450, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917142
12.
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
medRxiv;
2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790578
13.
Influenza Antiviral Shortages Reported by State and Territorial Public Health Officials, 2022-2023.
JAMA;
330(18): 1793-1795, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862007
14.
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial.
Immun Ageing;
20(1): 30, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37393237
15.
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020.
Open Forum Infect Dis;
10(6): ofad223, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37305842
16.
A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in Children.
J Pediatric Infect Dis Soc;
12(6): 342-352, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232430
17.
Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network.
Influenza Other Respir Viruses;
17(5): e13143, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246146
18.
Risk factors for infection with influenza A(H3N2) virus on a US university campus, October-November 2021.
Influenza Other Respir Viruses;
17(5): e13151, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246148
19.
Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
medRxiv;
2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016669
20.
Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022.
Emerg Infect Dis;
29(6): 1215-1219, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095080